Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/1991
04/13/1991WO1991005801A1 Dopamine releasing protein
04/13/1991CA2065442A1 Dopamine releasing protein
04/11/1991WO1991005787A1 Iminomethanodibenzo(a,d)cycloheptene derivatives as neuroprotectant agents
04/11/1991CA2067351A1 Neuroprotectant agents
04/11/1991CA2027126A1 Compositions and methods for treating or preventing infections in canine and feline animals
04/10/1991EP0421921A1 Double coated granules
04/10/1991EP0421861A1 2-Hydroxy thiophene- and furan derivatives condensed with a nitrogen containing ring, process for their preparation and their therapeutical application
04/10/1991EP0421819A1 Therapeutic nucleosides
04/10/1991EP0421581A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same
04/10/1991EP0421561A2 24-D-homo-vitamin D-derivatives, a process for their production, pharmaceutical compositions containing them and their use as medicines
04/10/1991EP0421380A1 Tumor-lysing cell inducer, method for inducing tumor-lysing cell and device for inducing tumor-lysing cell
04/10/1991EP0420953A1 8-beta-substituted ergolines, a process for manufacturing them, and their use
04/10/1991EP0420914A1 Cosmetic and skin treatment compositions.
04/10/1991EP0420849A1 Use of sucralfate
04/10/1991CN1050539A Biphenylmethane derivative and pharmacological use
04/09/1991US5006555 Antiinflammatory, antithrombin, respiratory system disorder treatment
04/09/1991US5006549 Antiinflammatory agents
04/09/1991US5006548 Hyaluronidase inhibitors, antiallergens, immunomodulators
04/09/1991US5006543 Diphenylethane derivatives
04/09/1991US5006518 Hormone inhibitors for inducing abortions; nontoxic
04/09/1991CA1282779C Polysaccharide ron substance, production of the same and use of the same
04/09/1991CA1282702C Regimen for treating osteoporosis
04/09/1991CA1282694C Agent comprising a plasmin inhibitor and a plasminogen activator for the treatment of thromboses
04/07/1991CA2027052A1 Therapeutic nucleosides
04/06/1991WO1991004667A1 Use of liposomes as carriers for metalloporphyrins
04/06/1991CA2042576A1 Use of liposomes as carriers for metalloporphyrins
04/05/1991CA2026713A1 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
04/04/1991WO1991004258A1 Inositol derivative and production thereof
04/04/1991WO1991004246A1 Method for preparing amino acid derivatives and therapeutical applications of same
04/04/1991WO1991004055A1 Treatment of autoimmune disease
04/04/1991WO1991004037A1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists
04/04/1991WO1991004027A1 New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
04/04/1991WO1991004024A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
04/04/1991WO1991004023A1 Isolating aminoarginine and use to block nitric oxide formation in body
04/04/1991WO1991001744A3 Uses of interleukin-4 and method for purifying it
04/04/1991WO1991000100A3 Toxin uses
04/04/1991CA2026707A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same
04/03/1991WO1991004737A1 Osteogenesis promoter
04/03/1991EP0420762A2 Heterocyclic compounds having lipoxygenase inhibiting activity
04/03/1991EP0420716A2 Benzodiazepines, process and intermediates for their preparation and their therapeutic use
04/03/1991EP0420570A2 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis
04/03/1991EP0420511A2 Heterocyclic derivatives
04/03/1991EP0420237A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same
04/03/1991EP0420193A2 Use of hydroxyurea or 1-ethyl-hydroxyurea for the suppression of bone marrow cells before transplantation
04/03/1991EP0420086A2 Pyrimidoindole derivatives and processes for preparation thereof
04/03/1991EP0420064A2 Substituted 2-amidotetralins as melatonin agonists and antagonists
04/03/1991EP0419856A2 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
04/03/1991EP0419610A1 New leukotriene b4 derivatives, process for producing them and their use as drugs.
04/03/1991EP0419534A1 Wound healing.
04/03/1991CN1050385A Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity
04/03/1991CA2026386A1 Derivatives of 2-hydroxythiopene and -furan fused with a nitrogen - containing ring, process for preparing these and their application in therapy
04/02/1991US5004811 Tetrapyrrole aminocarboxylic acids
04/02/1991US5004756 Anti-cancer activity potentiator
04/02/1991US5004748 Enzyme inhibitors, immunosuppresants; for controlling collagen metabolism
04/02/1991US5004742 Benzothiazine-1,1-dioxide derivatives
04/02/1991US5004735 Pharmaceutical compositions for the inhibition of tumor metastasis
04/02/1991CA1282549C Aminocarbonyl renin inhibitors
04/02/1991CA1282338C 5 .alpha.-REDUCTASE INHIBITOR
04/02/1991CA1282324C COMPOSITIONS FOR STIMULATING INTERGUMENTAL MELANOCYTES BY TOPICAL APPLICATIONOF ANALOGS OF .alpha.-MSH AND COMPOSITIONS FOR USE IN SAME
03/1991
03/30/1991WO1991005258A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2066674A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2026533A1 Biphenylmethane derivative and pharmacological use
03/30/1991CA2026227A1 Heterocyclic compound
03/30/1991CA2024258A1 Heterocyclic derivatives
03/29/1991CA2026123A1 Benzodiazepines, their process of production, intermediate products and applications in therapeutic practice
03/29/1991CA2023857A1 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
03/28/1991CA2023930A1 Method for the suppression of bone marrow
03/27/1991EP0419411A2 Additional alkanophenones
03/27/1991EP0419397A1 Substituted urea compounds and their preparation and use
03/27/1991EP0419327A1 Amino acid derivatives, method for their preparation and their therapeutic application
03/27/1991EP0419311A2 Prodrugs of carbonic anhydrase inhibitors
03/27/1991EP0419237A2 Treatment of non ulcerative dyspepsia with cyproheptadine
03/27/1991EP0419210A1 Novel benzimidazole compounds and their use
03/27/1991EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
03/27/1991EP0418990A2 13-Bromo and 13,14-dibromo ergoline, their preparation and their use
03/27/1991EP0418814A2 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method for preparing the same
03/27/1991EP0418696A2 Derivatives of aminoacids
03/27/1991EP0418648A1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors
03/27/1991EP0418233A1 Cysteine proteinase inhibitor
03/27/1991EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity.
03/27/1991CN1050198A Peptidase and isomerase inhibitors
03/27/1991CN1050190A Process for preparing sulphamoylthiophenes
03/27/1991CN1050183A New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholestrol acyl transferase
03/26/1991WO1991004274A1 Method for inhibiting growth of stem cells
03/26/1991WO1991004029A1 Orally administered porphyrins to control intestinal iron absorption
03/26/1991US5002972 Compound and composition of substituted hexenoic acid derivatives useful for treating thromboxane A2 mediated diseases
03/26/1991US5002968 Organogermanium compound, calcium metabolism
03/26/1991US5002948 Central Nervous System Disorders
03/26/1991US5002941 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
03/26/1991US5002935 Inclusion Complexing Hydroxypropylcyclodextrin with a Dihydropyridine-substituted Drug
03/26/1991US5002931 Human Hypothalmic Growth Hormone Releasing Factor
03/26/1991US5002753 Z Isomers, Halovinyl Substituents
03/26/1991CA2025958A1 Substituted 2-amidotetralins as melatonin agonists and antagonists
03/26/1991CA2025820A1 Pyrimidoindole derivatives and processes for preparation thereof
03/26/1991CA2025478A1 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxybenzofurans as inhibitors of leukotriene biosynthesis
03/23/1991CA2025860A1 Amino acid derivatives
03/23/1991CA2025849A1 Benzimidazole compounds and their use
03/23/1991CA2024421A1 Prodrugs of carbonic anhydrase inhibitors
03/21/1991WO1991003556A1 Recombinant product
03/21/1991WO1991003512A1 Cytoprotective fatty moiety compounds
1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 1564